Boston Scientific recalled 39,739 Encore 26 Inflation Devices on August 5, 2025. Foreign particles may migrate into balloon dilation catheters during use. Patients and healthcare providers must stop using the device immediately.
The Encore 26 Inflation Device is used with balloon dilation catheters to create and monitor pressure in the balloon and to deflate the balloon. An internal investigation determined that during use, foreign material particles could migrate from affected Encore 26 Inflation Devices into a balloon dilatation catheter.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Boston Scientific Corporation or your healthcare provider for instructions. Notification method: Letter
The recalled devices include model numbers H74904526011, H74904526052, M0067101140, M001151050, M001151062, and M00566670. These devices were distributed worldwide.
An internal investigation revealed that foreign material particles can migrate from the Encore 26 Inflation Device into the balloon dilation catheter. This poses a high risk during medical procedures.
No specific incidents or injuries have been reported at this time. The recall is precautionary due to potential contamination.
Stop using the Encore 26 Inflation Device immediately. Follow the recall instructions from Boston Scientific and contact your healthcare provider for guidance.
For more information, visit the FDA website at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2533-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.